ELL (gene)

RNA polymerase II elongation factor ELL is an enzyme that in humans is encoded by the ELL gene.

ELL
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 2DOA
Identifiers
Aliases	ELL, C19orf17, ELL1, MEN, PPP1R68, elongation factor for RNA polymerase II
External IDs	OMIM: 600284; MGI: 109377; HomoloGene: 4762; GeneCards: ELL; OMA:ELL - orthologs
Gene location (Human) Chr. Chromosome 19 (human) Band 19p13.11 Start 18,442,663 bp End 18,522,116 bp
Gene location (Mouse) Chr. Chromosome 8 (mouse) Band 8|8 B3.3 Start 70,992,107 bp End 71,045,508 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in right testis left testis buccal mucosa cell sperm sural nerve blood granulocyte gastrocnemius muscle muscle of thigh gonad Top expressed in Ileal epithelium saccule zygote otic placode secondary oocyte otic vesicle granulocyte primary oocyte muscle of thigh lactiferous gland More reference expression data BioGPS More reference expression data
Gene ontology Molecular function phosphatase binding protein binding Cellular component Cajal body nuclear speck histone locus body nucleoplasm transcription elongation factor complex nucleus Biological process regulation of transcription, DNA-templated snRNA transcription by RNA polymerase III negative regulation of phosphatase activity transcription elongation from RNA polymerase II promoter in utero embryonic development transcription by RNA polymerase II transcription, DNA-templated positive regulation of DNA-templated transcription, elongation positive regulation of transcription by RNA polymerase III positive regulation of transcription elongation from RNA polymerase II promoter snRNA transcription by RNA polymerase II Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 8178 13716 Ensembl ENSG00000105656 ENSMUSG00000070002 UniProt P55199 O08856 RefSeq (mRNA) NM_006532 NM_007924 RefSeq (protein) NP_006523 NP_031950 Location (UCSC) Chr 19: 18.44 – 18.52 Mb Chr 8: 70.99 – 71.05 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Interactions

ELL (gene) has been shown to interact with P53.

Further reading

• Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S (1994). "Two cellular proteins that bind to wild-type but not mutant p53". Proc. Natl. Acad. Sci. U.S.A. 91 (13): 6098–102. Bibcode:1994PNAS...91.6098I. doi:10.1073/pnas.91.13.6098. PMC 44145. PMID 8016121.
• Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
• Shilatifard A, Haque D, Conaway RC, Conaway JW (1997). "Structure and function of RNA polymerase II elongation factor ELL. Identification of two overlapping ELL functional domains that govern its interaction with polymerase and the ternary elongation complex". J. Biol. Chem. 272 (35): 22355–63. doi:10.1074/jbc.272.35.22355. PMID 9268387.
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
• Shilatifard A (1998). "Identification and purification of the Holo-ELL complex. Evidence for the presence of ELL-associated proteins that suppress the transcriptional inhibitory activity of ELL". J. Biol. Chem. 273 (18): 11212–7. doi:10.1074/jbc.273.18.11212. PMID 9556611.
• Li XY, Green MR (1998). "The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor". Genes Dev. 12 (19): 2992–6. doi:10.1101/gad.12.19.2992. PMC 317190. PMID 9765201.
• Shinobu N, Maeda T, Aso T, Ito T, Kondo T, Koike K, Hatakeyama M (1999). "Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53". J. Biol. Chem. 274 (24): 17003–10. doi:10.1074/jbc.274.24.17003. PMID 10358050.
• Schmidt AE, Miller T, Schmidt SL, Shiekhattar R, Shilatifard A (1999). "Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II". J. Biol. Chem. 274 (31): 21981–5. doi:10.1074/jbc.274.31.21981. PMID 10419521.
• Kim MK, Nikodem VM (2000). "hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation". Mol. Cell. Biol. 19 (10): 6833–44. doi:10.1128/MCB.19.10.6833. PMC 84680. PMID 10490622.
• Lavau C, Luo RT, Du C, Thirman MJ (2000). "Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice". Proc. Natl. Acad. Sci. U.S.A. 97 (20): 10984–9. Bibcode:2000PNAS...9710984L. doi:10.1073/pnas.190167297. PMC 27135. PMID 10995463.
• Simone F, Polak PE, Kaberlein JJ, Luo RT, Levitan DA, Thirman MJ (2001). "EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein". Blood. 98 (1): 201–9. doi:10.1182/blood.V98.1.201. PMID 11418481. S2CID 2577367.
• Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, Thirman MJ (2001). "The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis". Mol. Cell. Biol. 21 (16): 5678–87. doi:10.1128/MCB.21.16.5678-5687.2001. PMC 87288. PMID 11463848.
• Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ (2003). "ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties". Blood. 101 (6): 2355–62. doi:10.1182/blood-2002-06-1664. PMID 12446457.
• Polak PE, Simone F, Kaberlein JJ, Luo RT, Thirman MJ (2003). "ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia". Mol. Biol. Cell. 14 (4): 1517–28. doi:10.1091/mbc.E02-07-0394. PMC 153119. PMID 12686606.
• Wiederschain D, Kawai H, Gu J, Shilatifard A, Yuan ZM (2003). "Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL". Mol. Cell. Biol. 23 (12): 4230–46. doi:10.1128/MCB.23.12.4230-4246.2003. PMC 156137. PMID 12773566.